Selective Serotonin Reuptake Inhibitors and Myocardial Infarction
作者： William H. Sauer , Jesse A. Berlin , Stephen E. Kimmel
关键词:
摘要: Background Depression is an independent risk factor for myocardial infarction (MI). Selective serotonin reuptake inhibitors (SSRIs) may reduce this through attenuation of serotonin-mediated platelet activation in addition to treatment depression itself. Methods and Results A case-control study first MI smokers 30 65 years age was conducted among all 68 hospitals 8-county area during a 28-month period. Cases were patients hospitalized with MI. Approximately 4 community control subjects per case randomly selected from the same geographic using random digit dialing. Detailed information regarding use antidepressant medication as well other clinical demographic data obtained by telephone interview. total 653 cases 2990 participated. After adjustment, multivariable logistic regression, age, sex, race, education, exercise, quantity smoked day, body mass index, aspirin use, family history MI, number ...
sci-hub.se 参考文章(35)
RUTH M. MICKEY, SANDER GREENLAND, THE IMPACT OF CONFOUNDER SELECTION CRITERIA ON EFFECT ESTIMATION American Journal of Epidemiology. ,vol. 129, pp. 125- 137 ,(1989) , 10.1093/OXFORDJOURNALS.AJE.A115101
Stephen E Kimmel, Jesse A Berlin, Carolyn Miles, Jane Jaskowiak, Jeffrey L Carson, Brian L Strom, Risk of acute first myocardial infarction and use of nicotine patches in a general population Journal of the American College of Cardiology. ,vol. 37, pp. 1297- 1302 ,(2001) , 10.1016/S0735-1097(01)01124-X
Kate L. Lapane, Sally Zierkr, Thomas M. Lasater, Marilyn M. Barbour, Richard Carleton, Anne L. Hume, Is the Use of Psychotropic Drugs Associated with Increased Risk of Ischemic Heart Disease Epidemiology. ,vol. 6, pp. 376- 381 ,(1995) , 10.1097/00001648-199507000-00008
Steven E Kahn, The importance of the β-cell in the pathogenesis of type 2 diabetes mellitus The American Journal of Medicine. ,vol. 108, pp. 2- 8 ,(2000) , 10.1016/S0002-9343(00)00336-3
Félicien Karege, Philippe Bovier, Renata Stepanian, Alain Malafosse, The effect of clinical outcome on platelet G proteins of major depressed patients. European Neuropsychopharmacology. ,vol. 8, pp. 89- 94 ,(1998) , 10.1016/S0924-977X(97)00047-3
Daiga M. Helmeste, Siu W. Tang, Christopher Reist, Ryan Vu, Serotonin uptake inhibitors modulate intracellular Ca2+ mobilization in platelets. European Journal of Pharmacology. ,vol. 288, pp. 373- 377 ,(1995) , 10.1016/0922-4106(95)90051-9
Peter A. Shapiro, François Lespérance, Nancy Frasure-Smith, Christopher M. O'Connor, Brian Baker, Jan Wei Jiang, Paul Dorian, Wilma Harrison, Alexander H. Glassman, An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial) ☆ ☆☆ ★ American Heart Journal. ,vol. 137, pp. 1100- 1106 ,(1999) , 10.1016/S0002-8703(99)70369-8
Stephen M Delisi, Lukasz M Konopka, Francine L O’Connor, John W Crayton, Platelet Cytosolic Calcium Responses to Serotonin in Depressed Patients and Controls: Relationship to Symptomatology and Medication Biological Psychiatry. ,vol. 43, pp. 327- 334 ,(1998) , 10.1016/S0006-3223(97)00377-6
Hillel W Cohen, Geoffrey Gibson, Michael H Alderman, Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents∗∗Access the “Journal Club” discussion of this paper at http://www.elsevier.com/locate/ajmselect/ The American Journal of Medicine. ,vol. 108, pp. 2- 8 ,(2000) , 10.1016/S0002-9343(99)00301-0
P. Celada, M. Dolera, E. Alvarez, F. Artigas, Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. Relationship to clinical improvement Journal of Affective Disorders. ,vol. 25, pp. 243- 249 ,(1992) , 10.1016/0165-0327(92)90082-H